Short-term response to biologic therapy in psoriatic arthritis (PsA) is not influenced by disease duration at initiation of therapy
{{output}}
Objectives: We aimed to determine whether the short-term response to biologics in biologic-naïve psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. ... ...
